Company Financials

Boston Scientific Corporation Financials

United States dollar

business Boston Scientific Corporation Company Profile

Main Stock Listing

NYSE: BSX

Market Capitalization $140.40 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 50.46
Forward PE 27.20
Price to Sales TTM $7.23
Price to Book MRQ $5.98
Enterprise to Revenue 7.87
Enterprise to EBITDA 30.05

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 14.43%
Operating Margin 20.73%
Return on Assets TTM 5.76%
Return on Equity TTM 12.49%

Income Statement

Revenue TTM $19,349,000,192
Revenue per Share TTM $13.09
Quarterly Revenue Growth 20.30%
Gross Profit TTM $13,221,000,192
EBITDA $5,310,000,000
Net Income to Common TTM $2,791,000,064
Diluted EPS TTM $1.87
Quarterly Earnings Growth YoY 61.00%

Balance Sheet

Total Cash MRQ $1,275,000,064
Total Cash per Share MRQ $0.86
Total Debt MRQ $
Total Debt to Equity MRQ 50.97
Current Ratio MRQ 1.51
Book Value per Share MRQ $15.78

Cash Flow

Operating Cash Flow TTM $4,625,999,872
Levered Free Cash Flow TTM $3,065,125,120

BSX Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 1,482,283,281
Float Shares 1,478,320,850
Avg 10 Volume 6,635,155
Avg 30 Volume None
Shares Short 19,144,680
Short Ratio 1.91
Short % of Shares 1.29%
% Held by Insiders 0.19%
% Held by Institutions 94.44%

Stock Price Summary

Beta 0.67
Fifty Two Week Low $85.98
Fifty Two Week High $109.50
Fifty Two Week Change 4.25%
Day 50 MA $98.33
Day 200 MA $100.93

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date 2003-11-06